Breast Cancer Prognostic Biomarkers: Transcriptome & Proteome Analysis

Integrating the transcriptome and proteome reveals two prognostic biomarkers for breast cancer, particularly for the estrogen receptor positive subset.

JPM, Free Full-Text

Bulk and single-cell transcriptome profiling reveal the metabolic heterogeneity in human breast cancers: Molecular Therapy

Integrated Transcriptomics–Proteomics Analysis Identifies Molecular Phenotypic Alterations Associated with Colorectal Cancer

Pan-cancer proteomic map of 949 human cell lines - ScienceDirect

Frontiers Differential Integration of Transcriptome and Proteome Identifies Pan-Cancer Prognostic Biomarkers

Revolutionary Cancer Research Breakthroughs

Identification of Prognostic Biomarkers for Glioblastoma Based on Transcriptome and Proteome Association Analysis - Jiabin Wang, Shi Yan, Xiaoli Chen, Aowen Wang, Zhibin Han, Binchao Liu, Hong Shen, 2022

Survival analysis in breast cancer using proteomic data from four independent datasets

A 23 gene–based molecular prognostic score precisely predicts overall survival of breast cancer patients - eBioMedicine

Frontiers Integrated Transcriptome and Pathway Analyses Revealed Multiple Activated Pathways in Breast Cancer

Differential Proteome Profiling Analysis under Pesticide Stress by the Use of a Nano-UHPLC-MS/MS Untargeted Proteomic-Based Approach on a 3D-Developed Neurospheroid Model: Identification of Protein Interactions, Prognostic Biomarkers, and Potential